<?xml-stylesheet type="text/xsl" href="https://emersonexchange365.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>From Automation Islands to Connected Plants: A Practical Path for Life Sciences Manufacturers</title><link>/industries/lifesciences/b/life-sciences-blog/posts/from-automation-islands-to-connected-plants-a-practical-path-for-life-sciences-manufacturers</link><description>As explored in his recent interview in Pharmaceutical Processing World, Emerson’s Bruce Greenwald—drawing on decades of experience—explains that life sciences manufacturers are moving beyond isolated systems toward connected plants to achieve operational</description><dc:language>en-US</dc:language><generator>Telligent Community 13</generator></channel></rss>